Kobalava Z.D. - list of publications

ЭФФЕКТЫ И КЛИНИЧЕСКИЕ ИСХОДЫ РАННЕЙ ИНИЦИАЦИИ САКУБИТРИЛ/ВАЛСАРТАНА У ПАЦИЕНТОВ С ХРОНИЧЕСКОЙ СЕРДЕЧНОЙ НЕДОСТАТОЧНОСТЬЮ С НИЗКОЙ ФРАКЦИЕЙ ВЫБРОСА

Article

Кобалава Ж.Д., Галочкин С.А., Толкачева В.В., Багманова Н.Х.

Вестник Российского университета дружбы народов. Серия: Медицина. Федеральное государственное автономное образовательное учреждение высшего образования Российский университет дружбы народов (РУДН). Vol. 24. 2020. P. 125-134

ЭФФЕКТЫ МЕКСИДОЛА У ПАЦИЕНТОВ С ХИМ И ХСН II - III ФУНКЦИОНАЛЬНОГО КЛАССА

Article

Щулькин А.В., Казахмедов Э.Р., Галочкин С.А., Толкачева В.В., Кобалава Ж.Д.

Кардиология и сердечно-сосудистая хирургия. Vol. 13. 2020. P. 427-434

ФИКСИРОВАННАЯ ТРОЙНАЯ КОМБИНАЦИЯ АМЛОДИПИН/ИНДАПАМИД/ПЕРИНДОПРИЛА АРГИНИН - РАЦИОНАЛЬНЫЙ И БЕЗОПАСНЫЙ ВЫБОР ДЛЯ КОНТРОЛЯ АРТЕРИАЛЬНОГО ДАВЛЕНИЯ В РЕАЛЬНОЙ КЛИНИЧЕСКОЙ ПРАКТИКЕ (РЕЗУЛЬТАТЫ НАБЛЮДАТЕЛЬНОЙ ПРОГРАММЫ ДОКАЗАТЕЛЬСТВО)

Article

Кобалава Ж.Д., Толкачева В.В., Троицкая Е.А., Колесникова И.А., Маркова М.А.

Russian Journal of Cardiology. Silicea-Poligraf. Vol. 25. 2020. P. 117-124

EARLY STRUCTURAL AND FUNCTIONAL LEFT VENTRICULAR DISORDERS IN YOUNG PATIENTS WITH HYPERTENSION: A ROLE OF INSULIN RESISTANCE

Article

Shavarova E.K., Kobalava Z.D., Yezhova N.E., Khomova I.A., Bazdyreva E.I.

Russian Journal of Cardiology. Silicea-Poligraf. Vol. 25. 2020. P. 33-41

NEW GUIDELINES ON MANAGEMENT OF ARTERIAL HYPERTENSION: KEY SIMILARITIES AND DIFFERENCES

Article

Kobalava Z.D., Troitskaya E.A., Kolesnik E.L.

Rational Pharmacotherapy in Cardiology. Stolichnaya Izdatelskaya Kompaniya. Vol. 15. 2019. P. 105-114

THE INCIDENCE OF THE FIRST ONSET DIAGNOSED TYPE 2 DIABETES MELLITUS IN PATIENTS WITH CARDIOVASCULAR DISEASES

Article

Medovchshikov V.V., Yeshniyazov N.B., Tereshchenko E.A., Khasanova E.R., Kobalava Z.D.

European Journal of Heart Failure. Elsevier Science Publishing Company, Inc.. Vol. 21. 2019. P. 135-135

DIVERSE EFFECTS OF NEPRILYSIN INHIBITION BY SACUBITRIL/VALSARTAN ON DIFFERENT FORMS OF NATRIURETIC PEPTIDES IN PATIENTS WITH HFREF.

Article

Galochkin S.AS., Feygina E.E., Semenov A.G., Meray I.A., Kobalava Z.D.

European Journal of Heart Failure. Elsevier Science Publishing Company, Inc.. Vol. 21. 2019. P. 225-226

THE INCIDENCE OF CHRONIC HEART FAILURE IN PATIENTS WITH TYPE 2 DIABETES MELLITUS

Article

Yeshniyazov N.B., Medovchshikov V.V., Tereshchenko E.A., Khasanova E.R., Kobalava Z.D.

European Journal of Heart Failure. Elsevier Science Publishing Company, Inc.. Vol. 21. 2019. P. 253-253

EVALUATION OF LUNG ULTRASOUND FOR DIFFERENTIAL DIAGNOSIS OF PNEUMONIA AND HEART FAILURE DECOMPENSATION

Article

Zorya O.O., Omar S., Bayarsaikhan, Rachina S.A., Kobalava Z.D.

European Journal of Heart Failure. Elsevier Science Publishing Company, Inc.. Vol. 21. 2019. P. 434-434

INTERACTION BETWEEN CENTRAL HEMODYNAMICS AND LEFT VENTRICULAR GEOMETRY IN PATIENTS WITH PRESERVED EJECTION FRACTION

Article

Shavarov A., Kiyakbaev G.K., Kobalava Z.D.

European Journal of Heart Failure. Elsevier Science Publishing Company, Inc.. Vol. 21. 2019. P. 465-465

PHASE II STUDY OF SINGLE/REPEATED DOSES OF ACUMAPIMOD (BCT197) TO TREAT ACUTE EXACERBATIONS OF COPD

Article

Strâmbu I.R., Kobalava Z.D., Magnusson B.P., MacKinnon A., Parkin J.M.

COPD: Journal of Chronic Obstructive Pulmonary Disease. Taylor and Francis Ltd. Vol. 16. 2019. P. 344-353

THE MODERN PARADIGM OF PATHOPHYSIOLOGY, PREVENTION AND TREATMENT OF HEART FAILURE IN TYPE 2 DIABETES MELLITUS

Article

Kobalava Z.D., Medovchshikov V.V., Yeshniyazov N.B., Khasanova E.R.

Russian Journal of Cardiology. Silicea-Poligraf. Vol. 24. 2019. P. 98-111

A MODERN VIEW ON THE PATHOGENESIS, DIAGNOSIS AND TREATMENT OF ALCOHOLIC CARDIOMYOPATHY

Article

Kobalava Z.D., Lazarev P.V., Goncharov A.S.

Russian Journal of Cardiology. Silicea-Poligraf. Vol. 24. 2019. P. 164-172

LEFT ATRIAL PHASIC FUNCTION IN PATIENTS WITH HYPERTENSION AND RECURRENT ATRIAL FIBRILLATION: GENDER DIFFERENCES OF THE RELATIONSHIP WITH DIASTOLIC DYSFUNCTION AND CENTRAL AORTIC PRESSURE

Article

Kokhan E.V., Ozova E.M., Romanova V.A., Klyakbaev G.X., Kobalava Z.D.

Rational Pharmacotherapy in Cardiology. Stolichnaya Izdatelskaya Kompaniya. Vol. 15. 2019. P. 622-633

HYDROCHLOROTHIAZIDE AND THE RISK OF NON-MELANOMA SKIN CANCER: A CRITICAL REVIEW

Article

Kobalava Z.D., Kokhan E.V., Kiyakbaev G.K.

Arterial Hypertension (Russian Federation). All-Russian Public Organization Antihypertensive League. Vol. 25. 2019. P. 376-388

ELEVATED HEART RATE IN HYPERTENSION AND CORONARY ARTERY DISEASE: RISK FACTOR OR RISK MARKER IN PATIENTS WITH PRESERVED LEFT VENTRICULAR EJECTION FRACTION

Article

Kokhan E.V., Kiyakbaev G.K., Kobalava Z.D.

Arterial Hypertension (Russian Federation). All-Russian Public Organization Antihypertensive League. Vol. 25. 2019. P. 389-406

EFFECTS OF FIXED-DOSE INDAPAMIDE/PERINDOPRIL COMBINATION ON ARTERIAL FUNCTION IN PATIENTS WITH HYPERTENSION AND CHRONIC KIDNEY DISEASE: KEY RESULTS OF THE CAMERTON PROGRAM

Article

Kobalava Z.D., Kireeva V.V., Chernomorets V.S., Troitskaya E.A., Stavtseva Y.V.

Russian Journal of Cardiology. Silicea-Poligraf. Vol. 24. 2019. P. 87-95

DABIGATRAN ETEXILATE IN PATIENTS WITH NONVALVULAR ATRIAL FIBRILLATION: BENEFITS OF APPLICATION IN CERTAIN CLINICAL SITUATIONS

Article

Baranova E.I., Kobalava Z.D.

Russian Journal of Cardiology. Silicea-Poligraf. Vol. 24. 2019. P. 133-141

ASSOCIATION OF THE PLASMA ALDOSTERONE, ARTERIAL STIFFNESS AND LEFT ATRIUM VOLUME INDEX IN HYPERTENSIVE PATIENTS

Article

Shavarova E., Kravtsova O.A., Chomova I.A., Kobalava Z.D.

European Heart Journal. Vol. 40. 2019. P. 2181-2181

MYOCARDIAL INFARCTION WITH NON-OBSTRUCTIVE CORONARY ARTERIES: CONTEMPORARY DIAGNOSTIC AND MANAGEMENT APPROACHES

Article

Hoang T.H., Lazarev P.V., Maiskov V.V., Meray I.A., Kobalava Z.D.

Rational Pharmacotherapy in Cardiology. Stolichnaya Izdatelskaya Kompaniya. Vol. 15. 2019. P. 881-891

SINGLE-PILL COMBINATION OF PERINDOPRIL ARGININE/INDAPAMIDE IMPROVES THE VASCULAR FUNCTION IN THE PATIENTS WITH ARTERIAL HYPERTENSION AND CHRONIC KIDNEY DISEASE IN THE REAL CLINICAL SETTING

Article

Fernando W.D., Chernomorets V., Troistkaya Elena, Kobalava Zhanna

SCIENCE4HEALTH 2019. Клинические и теоретические аспекты современной медицины. Российский университет дружбы народов (РУДН). 2019. 36 p.

COGNITIVE DYSFUNCTION AT THE BACKGROUND OF ATRIAL FIBRILLATION: CLINICAL-PATHOLOGICAL ASPECTS, DIAGNOSTICS AND PREVENTION, ISSUES OF THE USE OF THE APPLICATION OF ANTICOAGULANT THERAPY

Article

Kobalava Z.D., Lazarev P.V., Fedorova D.N.

Kardiologiia. KlinMed Consulting. Vol. 59. 2019. P. 66-77

TYPE 2 DIABETES MELLITUS AND HEART FAILURE: INNOVATIVE POSSIBILITIES FOR MANAGEMENT OF PROGNOSIS

Article

Kobalava Z.D., Yeshniyazov N.V., Medovchshikov V.V., Khasanova E.R.

Kardiologiia. KlinMed Consulting. Vol. 59. 2019. P. 76-87

POSSIBILITIES OF CLINICAL USE OF EZETIMIBE OTRIO (JSC “AKRIKHIN”, RUSSIA) IN PATIENTS WITH HIGH AND VERY HIGH CARDIOVASCULAR RISK WHO HAVE NOT REACHED THE TARGET VALUES OF LIPID METABOLISM. CONCLUSION OF THE BOARD OF EXPERTS

Article

Kobalava J.D., Gurevich V.S., Galyavich A.M., Kaminnyi A.I., Kashtalap V.V., Mareev V.Y., Susekov A.V., Shaposhnik I.I.

Kardiologiia. KlinMed Consulting. Vol. 59. 2019. P. 47-57

MARKERS OF ENDOTHELIAL DYSFUNCTION, CYTOKINE STATUS, COLLAGEN COL1A1_1 GENE ON THE DEVELOPMENT OF LIVER FIBROSIS IN IN ALCOHOL ABUSERS

Article

Ivanov A.S., Tarasenko E.V., Garmasch I.V., Myandina G.I., Arisheva O.S., Zheludova E.M., Azova M.M., Terebilina N.N., Baronets V.Yu., Kobalava Zh.D.

Patologicheskaya Fiziologiya i Eksperimentalnaya Terapiya. Vol. 63. 2019. P. 55-63

Кобалава Ж.Д.

List of records

ЭФФЕКТЫ И КЛИНИЧЕСКИЕ ИСХОДЫ РАННЕЙ ИНИЦИАЦИИ САКУБИТРИЛ/ВАЛСАРТАНА У ПАЦИЕНТОВ С ХРОНИЧЕСКОЙ СЕРДЕЧНОЙ НЕДОСТАТОЧНОСТЬЮ С НИЗКОЙ ФРАКЦИЕЙ ВЫБРОСА

ЭФФЕКТЫ МЕКСИДОЛА У ПАЦИЕНТОВ С ХИМ И ХСН II - III ФУНКЦИОНАЛЬНОГО КЛАССА

EARLY STRUCTURAL AND FUNCTIONAL LEFT VENTRICULAR DISORDERS IN YOUNG PATIENTS WITH HYPERTENSION: A ROLE OF INSULIN RESISTANCE

NEW GUIDELINES ON MANAGEMENT OF ARTERIAL HYPERTENSION: KEY SIMILARITIES AND DIFFERENCES

THE INCIDENCE OF THE FIRST ONSET DIAGNOSED TYPE 2 DIABETES MELLITUS IN PATIENTS WITH CARDIOVASCULAR DISEASES

DIVERSE EFFECTS OF NEPRILYSIN INHIBITION BY SACUBITRIL/VALSARTAN ON DIFFERENT FORMS OF NATRIURETIC PEPTIDES IN PATIENTS WITH HFREF.

THE INCIDENCE OF CHRONIC HEART FAILURE IN PATIENTS WITH TYPE 2 DIABETES MELLITUS

EVALUATION OF LUNG ULTRASOUND FOR DIFFERENTIAL DIAGNOSIS OF PNEUMONIA AND HEART FAILURE DECOMPENSATION

INTERACTION BETWEEN CENTRAL HEMODYNAMICS AND LEFT VENTRICULAR GEOMETRY IN PATIENTS WITH PRESERVED EJECTION FRACTION

PHASE II STUDY OF SINGLE/REPEATED DOSES OF ACUMAPIMOD (BCT197) TO TREAT ACUTE EXACERBATIONS OF COPD

THE MODERN PARADIGM OF PATHOPHYSIOLOGY, PREVENTION AND TREATMENT OF HEART FAILURE IN TYPE 2 DIABETES MELLITUS

A MODERN VIEW ON THE PATHOGENESIS, DIAGNOSIS AND TREATMENT OF ALCOHOLIC CARDIOMYOPATHY

LEFT ATRIAL PHASIC FUNCTION IN PATIENTS WITH HYPERTENSION AND RECURRENT ATRIAL FIBRILLATION: GENDER DIFFERENCES OF THE RELATIONSHIP WITH DIASTOLIC DYSFUNCTION AND CENTRAL AORTIC PRESSURE

HYDROCHLOROTHIAZIDE AND THE RISK OF NON-MELANOMA SKIN CANCER: A CRITICAL REVIEW

ELEVATED HEART RATE IN HYPERTENSION AND CORONARY ARTERY DISEASE: RISK FACTOR OR RISK MARKER IN PATIENTS WITH PRESERVED LEFT VENTRICULAR EJECTION FRACTION

EFFECTS OF FIXED-DOSE INDAPAMIDE/PERINDOPRIL COMBINATION ON ARTERIAL FUNCTION IN PATIENTS WITH HYPERTENSION AND CHRONIC KIDNEY DISEASE: KEY RESULTS OF THE CAMERTON PROGRAM

DABIGATRAN ETEXILATE IN PATIENTS WITH NONVALVULAR ATRIAL FIBRILLATION: BENEFITS OF APPLICATION IN CERTAIN CLINICAL SITUATIONS

ASSOCIATION OF THE PLASMA ALDOSTERONE, ARTERIAL STIFFNESS AND LEFT ATRIUM VOLUME INDEX IN HYPERTENSIVE PATIENTS

MYOCARDIAL INFARCTION WITH NON-OBSTRUCTIVE CORONARY ARTERIES: CONTEMPORARY DIAGNOSTIC AND MANAGEMENT APPROACHES

SINGLE-PILL COMBINATION OF PERINDOPRIL ARGININE/INDAPAMIDE IMPROVES THE VASCULAR FUNCTION IN THE PATIENTS WITH ARTERIAL HYPERTENSION AND CHRONIC KIDNEY DISEASE IN THE REAL CLINICAL SETTING

COGNITIVE DYSFUNCTION AT THE BACKGROUND OF ATRIAL FIBRILLATION: CLINICAL-PATHOLOGICAL ASPECTS, DIAGNOSTICS AND PREVENTION, ISSUES OF THE USE OF THE APPLICATION OF ANTICOAGULANT THERAPY

TYPE 2 DIABETES MELLITUS AND HEART FAILURE: INNOVATIVE POSSIBILITIES FOR MANAGEMENT OF PROGNOSIS

POSSIBILITIES OF CLINICAL USE OF EZETIMIBE OTRIO (JSC “AKRIKHIN”, RUSSIA) IN PATIENTS WITH HIGH AND VERY HIGH CARDIOVASCULAR RISK WHO HAVE NOT REACHED THE TARGET VALUES OF LIPID METABOLISM. CONCLUSION OF THE BOARD OF EXPERTS

MARKERS OF ENDOTHELIAL DYSFUNCTION, CYTOKINE STATUS, COLLAGEN COL1A1_1 GENE ON THE DEVELOPMENT OF LIVER FIBROSIS IN IN ALCOHOL ABUSERS

Other authors

Varlamov A.V.

Gudkov K.M.